Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
LYZZ Capital: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
LYZZ Capital
LYZZ Capital
Active
Website
LinkedIn
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 1, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at LYZZ Capital.
PH
Peter Haberz
Principal
KL
Kevin Li
Founding Managing Partner
Leadership Team
Key people at LYZZ Capital.
Peter Haberz
Principal
Kevin Li
Founding Managing Partner
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Nov 7, 2025
Onchilles Pharma
$25.0M Series A
—
InVivium Capital
,
Kennedy Lewis Investment Management
,
Lincoln Park Capital
,
University of Chicago Medicine
Aug 28, 2025
Wugen
$115.0M Other Equity
Fidelity Management & Research Company
Abingworth
, Aisling Capital
, Intermediate Capital Group
,
Lightchain Capital
, Niall O'Donnell
,
Tybourne Capital Management
Jun 1, 2022
MojiaBio
$80.0M Series B
Temasek
BASF Venture Capital
,
Bits x Bites
, Bo Bai
,
Sento Investment
Dec 1, 2021
OncoMyx Therapeutics
$50.0M Series B
B Capital Group
, Benjamin Rovinski, Ph.D.
Boehringer Ingelheim
,
City Hill Ventures
,
Delos Capital
,
Korea Investment Partners
,
Madison Partners
,
Xeraya Capital
Jul 1, 2021
Wugen
$170.0M Series B
Abingworth
, Bosun Hau
RiverVest
, Aisling Capital
,
Alexandria Venture Investments
, Falcon Edge Capital
, Fidelity Management & Research Company
, Peter Kiener
,
Lightchain Capital
, John McKearn
,
Sands Capital
,
Velosity Capital
Jun 10, 2021
Onchilles Pharma
$7.0M Series A
Court R. Turner
University of Chicago
Mar 11, 2021
Neurelis
$114.0M Series D
—
Cormorant Asset Management
,
Decheng Capital
, HBM Healthcare Investments
,
Philos & Partners
Feb 19, 2021
Jumpcode Genomics
$21.0M Series B
Arboretum Ventures
, Michael Liang
—
Oct 22, 2018
Qpex Biopharma
$33.0M Series A
Carol Gallagher
Adams Street Partners
,
Biomedical Advanced Research and Development Authority
,
Hatteras Venture Partners
, Stanford University
Jun 1, 2018
Alpha Biopharma
$37.0M Series A
Qiming Venture Partners
TF Fund